| CD4+ count–guided interruption of antiretroviral treatment Strategies for Management of Antiretroviral Therapy (SMART) Study Group New England Journal of Medicine 355 (22), 2283-2296, 2006 | 2711 | 2006 |
| Combination antiretroviral therapy and the risk of myocardial infarction Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group New England Journal of Medicine 349 (21), 1993-2003, 2003 | 2134 | 2003 |
| Targeted tuberculin testing and treatment of latent tuberculosis infection American Thoracic Society, Centers for Disease Control and Prevention Am J Respir Crit Care Med 161, S221-S247, 2000 | 1571* | 2000 |
| Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study Data Collection on Adverse Events of Anti-HIV Drugs Study Group Archives of internal medicine 166 (15), 1632-1641, 2006 | 1518 | 2006 |
| Cardiovascular disease risk factors in HIV patients–association with antiretroviral therapy. Results from the DAD study N Friis-Møller, R Weber, P Reiss, R Thiébaut, O Kirk, AA Monforte, ... Aids 17 (8), 1179-1193, 2003 | 1414 | 2003 |
| Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration D: A: D Study Group The Lancet 371 (9622), 1417-1426, 2008 | 1192 | 2008 |
| Trends in underlying causes of death in people with HIV from 1999 to 2011 (D: A: D): a multicohort collaboration CJ Smith, L Ryom, R Weber, P Morlat, C Pradier, P Reiss, JD Kowalska, ... The Lancet 384 (9939), 241-248, 2014 | 1168 | 2014 |
| Basic documents: (including amendments adopted up to 31 May 2019) World Health Organization World Health Organization, 2020 | 983 | 2020 |
| Microfluidics-based diagnostics of infectious diseases in the developing world CD Chin, T Laksanasopin, YK Cheung, D Steinmiller, V Linder, H Parsa, ... Nature medicine 17 (8), 1015-1019, 2011 | 943 | 2011 |
| Timing of initiation of antiretroviral drugs during tuberculosis therapy SS Abdool Karim, K Naidoo, A Grobler, N Padayatchi, C Baxter, A Gray, ... New England Journal of Medicine 362 (8), 697-706, 2010 | 935 | 2010 |
| USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus Centers for Disease Control and Prevention MMWR 46 (RR‐12), 1-48, 1997 | 865* | 1997 |
| Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse … SW Worm, C Sabin, R Weber, P Reiss, W El-Sadr, F Dabis, S De Wit, ... The Journal of infectious diseases 201 (3), 318-330, 2010 | 856 | 2010 |
| Guidelines for preventing opportunistic infections among HIV-infected persons—2002: recommendations of the US Public Health Service and the Infectious Diseases Society of America PH Masur, JE Kaplan, KK Holmes Annals of internal medicine 137 (5_Part_2), 435-478, 2002 | 847 | 2002 |
| Integration of antiretroviral therapy with tuberculosis treatment SS Abdool Karim, K Naidoo, A Grobler, N Padayatchi, C Baxter, AL Gray, ... New England Journal of Medicine 365 (16), 1492-1501, 2011 | 656 | 2011 |
| Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D: A: D) study S De Wit, CA Sabin, R Weber, SW Worm, P Reiss, C Cazanave, ... Diabetes care 31 (6), 1224-1229, 2008 | 624 | 2008 |
| Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study N Friis-Møller, R Thiebaut, P Reiss, R Weber, A D'Arminio Monforte, ... European journal of cardiovascular prevention & rehabilitation 17 (5), 491-501, 2010 | 468 | 2010 |
| Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles? E Fontas, F Van Leth, CA Sabin, N Friis-Møller, M Rickenbach, ... The Journal of infectious diseases 189 (6), 1056-1074, 2004 | 431 | 2004 |
| Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. M Marmor, DC Des Jarlais, H Cohen, SR Friedman, ST Beatrice, N Dubin, ... AIDS (London, England) 1 (1), 39-44, 1987 | 421 | 1987 |
| Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral‐naive cohort WM El‐Sadr, CM Mullin, A Carr, C Gibert, C Rappoport, F Visnegarwala, ... HIV medicine 6 (2), 114-121, 2005 | 400 | 2005 |
| The use of the Framingham equation to predict myocardial infarctions in HIV‐infected patients: comparison with observed events in the D: A: D study MG Law, N Friis‐Møller, WM El‐Sadr, R Weber, P Reiss, ... HIV medicine 7 (4), 218-230, 2006 | 392 | 2006 |
